Uveitis Trial, Recruiting NCT07518134 Sponsor: Jaeb Center for Health Research Condition: Uveitis
Back to Uveitis

Uveitis Trial, Recruiting

NCT07518134
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children under 17 years old who have been recently diagnosed with uveitis (an eye inflammation condition) within the last 6 months
  • Children and young people under 18 years old who were diagnosed with uveitis more than 6 months ago
  • People with any type of uveitis, whether caused by an infection or not, and in any part of the eye
  • People whose uveitis is currently active (causing symptoms) or currently inactive (under control), regardless of whether they are on treatment, have been treated before, or have never been treated but are being monitored

Who may not be able to join:

  • People who have uveitis in both eyes where each eye has a different underlying cause
  • People whose uveitis was caused by an eye injury
  • People whose uveitis developed after eye surgery
  • People who have a close family member (such as a parent, guardian, spouse, child, or sibling) who works directly on this study at the trial site, or who works for the JAEB Center for Health Research
  • People who have certain other eye conditions, including retinoblastoma, Coat's disease, retinitis pigmentosa, inherited retinal degeneration, juvenile xanthogranuloma (JXG), or cancer affecting the eye (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kara C LaMattina, MD, Department of Ophthalmology, Boston University School of Medicine

Phone: 813-975-8690

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jaeb Center for Health Research
Registry
ClinicalTrials.gov
Start date
14 April 2026
Est. completion
1 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Frequency of uveitis subtypes in children <18 years of age

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov